Pre-ESRD

101427


9
9
Early-CKD
9Pre-ESRD

9
2

.95113b45
(Pre-ESRD
)

.100

Early-CKD123a

.1004.04Early-CKDPre-ESRD

eGFR90

eGFR 60~89.9

3a

eGFR 45~59.9

3b

eGFR 30~44.9

eGFR 15~29.9

eGFR 15

CKD

Pre-ESRD


(Early-CKD)

Early-CKD
10011
Guideline

eGFR()
Upcr()LDL(
)


90



1
2:
6
(42e-learning)

:
20%(
)


z Urine protein/creatinine
ratio (UPCR) 1000 mg/gmeGFR45
ml/min/1.73 m2PreESRD(Stage 3b
)
z 2

z (180)
1

10



z CKDstage 2stage 1
z eGFR(eGFR)
2

z 130/80 mmHg
z HbA1c7.0%
z (LDL)130 mg/dl
z ()

11

12



2
50%
2
1.CKDstage 2stage 1
2.eGFR(eGFR)2

9
9
9
9

140/90 mmHg130/80 mmHg

HbA1c7.0%7.0%
(LDL)130 mg/dl130 mg/dl
()

12
400

13


100112()
(P4301C)
200 /

14,285,160

(P4302C)
200 /

5,502,900

(P4303C)
200/

65,200

11,200

19,864,460

:101.4.3
100.01~12

14

(1)

CKD1

CKD2

CKD3a

A/B

18

417

2,026

3,130

5,588

10,744 123,366

8.7%

63

416

1,937

4,163

6,516

12,616 151,306

8.3%

110

304

1,687

4,111

5,902

11,700

73,295

16.0%

486

604

7,620

16,201

18,709

42,530

61,282

69.4%

677

1,671

13,270

27,605

36,715

77,590

:1.101.2.16
100.01~12
2.100
15

(2)

16

(3)

:VPN
17

(4)

B/A

140/90
mmHg

11,138

14.35%

1524

13.7%

HbA1c

7.0%

29,586

68.26%

2262

7.6%

(LDL)

130
mg/dl

20,444

26.35%

3952

19.3%

12,201

15.72%

1023

8.4%

1.101.2.16
2.(LDL)
100(77,590)HbA1c
43,343
3.
18


1006771,671
77,590
()

z 13.7%
z HbA1c 7.6%
z (LDL)19.3%
z 8.4%

10049CKD
2674

19

Pre-ESRD

20

21

22

(1)

1
2
(1)

(2)
(3)

3
1
23

(2)

1
2

3(Upcr < 200 mg/gm)

4(180)
1

24


P3402C
Stage 3b451
11200
P3403C
Stage 3b45
311600
P3404C
P3403C1
1600

P3405C
Stage 3b451
1600
P3406C Stage 3b4
Stage 3b41
11500
P3407C Stage 5
Stage 51
13000

P3408C
1
11000
P3409C
Stage 3b45
1
12000

25

9511-12

96

97

98

99

100

51,969

49,898

59,894

44,120

48,420

84,000

2,034

8,492

40,861

66,612

87,652

99,215

3.91%

17.02%

68.22%

150.98%

181.03%

118.11%

(3)

(3)

(3)

11001~3+4
2951195.96
3100%

26

9511100Pre-ESRD

9511~12

721

28

749

96

9,653

409

10,062

97

13,626

382

14,008

98

17,118

676

17,794

99

17,272

617

17,889

100

17,683

803

18,486

:(P3402C

27

Pre-ESRD
()
.
. Pre-ESRDeGFR

()100CKD Stage 3b4

5,7846%
()CKD Stage 5
2,229-2%
()36
3%

28

Pre-ESRD
()

stage 5

(A)

96

97

98

99

189

1,077

1,575

1,989

(B )

9,468

9,663

9,742

10,034

(A/B)

2.00%

11.15%

16.17%

19.82%

1.(A):(P3405C)
2.
(1) ( ) ( 3 )
(2) 3
3.
4.

(B) ( ID+ )

29

Pre-ESRD
()

95
96
97
98
99

(A )

(B )

= (B )/ (A )* 1 0 ^ 6

=( - )/

2 2 ,8 7 6 ,5 2 7
2 2 ,9 5 8 ,3 6 0
2 3 ,0 3 7 ,0 3 1
2 3 ,1 1 9 ,7 7 2
2 3 ,1 6 2 ,1 2 3

9 ,0 3 8
9 ,4 6 8
9 ,6 6 3
9 ,7 4 2
1 0 ,0 3 4

3 9 5 .1
4 1 2 .4
4 1 9 .5
4 2 1 .4
4 3 3 .2

4 .3 8 %
1 .7 1 %
0 .4 6 %
2 .8 1 %

1 . (A ) ( )
2 .
(1 ) ( )
( 3 )
(2 ) 3
3 .

4 . (B ) ( ID + )

30

1.-2%
2.()15%
3.3%
4.14%

31

32